Alba Bigoloni

1.1k total citations
31 papers, 355 citations indexed

About

Alba Bigoloni is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Alba Bigoloni has authored 31 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 21 papers in Virology and 7 papers in Emergency Medicine. Recurrent topics in Alba Bigoloni's work include HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (21 papers) and HIV/AIDS Research and Interventions (8 papers). Alba Bigoloni is often cited by papers focused on HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (21 papers) and HIV/AIDS Research and Interventions (8 papers). Alba Bigoloni collaborates with scholars based in Italy, United States and Sweden. Alba Bigoloni's co-authors include Antonella Castagna, Adriano Lazzarin, Laura Galli, Nicola Gianotti, Stefania Salpietro, Monica Guffanti, Silvia Nozza, Vincenzo Spagnuolo, Hamid Hasson and PierMarco Piatti and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and AIDS.

In The Last Decade

Alba Bigoloni

31 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alba Bigoloni Italy 11 247 203 142 59 25 31 355
Monica Guffanti Italy 11 206 0.8× 143 0.7× 158 1.1× 82 1.4× 39 1.6× 28 349
Salvatore Rocca Italy 9 201 0.8× 200 1.0× 136 1.0× 151 2.6× 22 0.9× 10 501
Fabienne Caby France 9 232 0.9× 231 1.1× 123 0.9× 92 1.6× 16 0.6× 26 365
P. de Truchis France 10 351 1.4× 251 1.2× 147 1.0× 201 3.4× 31 1.2× 20 589
L Caggese Italy 8 461 1.9× 318 1.6× 115 0.8× 150 2.5× 29 1.2× 9 597
Ana Barrios Spain 10 243 1.0× 194 1.0× 83 0.6× 65 1.1× 69 2.8× 19 371
Rosmeri Kuhmmer Lazzaretti Brazil 13 104 0.4× 95 0.5× 114 0.8× 55 0.9× 11 0.4× 18 298
Shannon Schrader United States 11 582 2.4× 487 2.4× 158 1.1× 91 1.5× 15 0.6× 18 700
Frederikke F. Rönsholt Denmark 10 156 0.6× 123 0.6× 166 1.2× 134 2.3× 37 1.5× 24 411
Godfrey C. Burns United States 6 305 1.2× 154 0.8× 201 1.4× 69 1.2× 8 0.3× 7 481

Countries citing papers authored by Alba Bigoloni

Since Specialization
Citations

This map shows the geographic impact of Alba Bigoloni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alba Bigoloni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alba Bigoloni more than expected).

Fields of papers citing papers by Alba Bigoloni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alba Bigoloni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alba Bigoloni. The network helps show where Alba Bigoloni may publish in the future.

Co-authorship network of co-authors of Alba Bigoloni

This figure shows the co-authorship network connecting the top 25 collaborators of Alba Bigoloni. A scholar is included among the top collaborators of Alba Bigoloni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alba Bigoloni. Alba Bigoloni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muccini, Camilla, Monica Guffanti, Vincenzo Spagnuolo, et al.. (2022). Association between low levels of HIV-1 DNA and HLA class I molecules in chronic HIV-1 infection. PLoS ONE. 17(3). e0265348–e0265348. 2 indexed citations
2.
Saladini, Francesco, Franco Maggiolo, Francesca Vichi, et al.. (2020). In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patients. Journal of Antimicrobial Chemotherapy. 75(9). 2547–2553. 11 indexed citations
3.
Muccini, Camilla, Vincenzo Spagnuolo, Diana Canetti, et al.. (2020). Cerebrospinal fluid viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance. AIDS. 34(14). 2152–2155. 1 indexed citations
4.
Spagnuolo, Vincenzo, Laura Galli, Alba Bigoloni, et al.. (2019). <p>A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study</p>. Drug Design Development and Therapy. Volume 13. 477–479. 2 indexed citations
5.
Galli, Laura, Andrea Poli, Nicola Gianotti, et al.. (2018). Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load. PLoS ONE. 13(2). e0191300–e0191300. 1 indexed citations
6.
Galli, Laura, Vincenzo Spagnuolo, Alba Bigoloni, et al.. (2016). Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial. Journal of Antimicrobial Chemotherapy. 71(6). 1637–1642. 7 indexed citations
7.
Ferretti, Francesca, Alba Bigoloni, Laura Galli, et al.. (2016). Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients. Medicine. 95(28). e4144–e4144. 6 indexed citations
8.
Merli, Marco, Laura Galli, Antonella Castagna, et al.. (2016). Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patients.. PubMed. 39(2). 110–3. 11 indexed citations
9.
Cavarelli, Mariangela, Alba Bigoloni, Monica Tolazzi, et al.. (2014). Complexity and Dynamics of HIV-1 Chemokine Receptor Usage in a Multidrug-Resistant Adolescent. AIDS Research and Human Retroviruses. 30(12). 1243–1250. 3 indexed citations
10.
Spagnuolo, Vincenzo, Laura Galli, Alba Bigoloni, et al.. (2014). Atazanavir/ritonavir monotherapy as maintenance strategy in HIV‐1 treated subjects with viral suppression: 96‐week analysis results of the MODAT study. Journal of the International AIDS Society. 17(4S3). 19806–19806. 6 indexed citations
11.
Galli, Laura, Alba Bigoloni, Simona Bossolasco, et al.. (2014). Unboosted atazanavir with lamivudine/emtricitabine for patients with long‐lasting virological suppression. Journal of the International AIDS Society. 17(4S3). 19811–19811. 2 indexed citations
12.
Galli, Laura, Vincenzo Spagnuolo, Andrea Poli, et al.. (2014). Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy. AIDS. 28(16). 2407–2415. 11 indexed citations
13.
Galli, Laura, Stefania Salpietro, G. Pellicciotta, et al.. (2012). Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy. European Journal of Epidemiology. 27(8). 657–665. 69 indexed citations
14.
Cossarini, Francesca, Andrea Galli, Laura Galli, et al.. (2012). Immune recovery and T cell subset analysis during effective treatment with maraviroc. Journal of Antimicrobial Chemotherapy. 67(10). 2474–2478. 10 indexed citations
15.
Spagnuolo, Vincenzo, Laura Galli, Stefania Salpietro, et al.. (2011). Ten‐year survival among HIV‐1‐infected subjects with AIDS or non‐AIDS‐defining malignancies. International Journal of Cancer. 130(12). 2990–2996. 21 indexed citations
16.
17.
Soria, Alessandro, Anna Danise, Laura Galli, et al.. (2010). Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: A pilot randomised trial. Journal of Clinical Virology. 47(3). 253–257. 5 indexed citations
18.
Gianotti, Nicola, Laura Galli, Beatrice Barda, et al.. (2010). Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patients. HIV Medicine. 12(2). 109–117. 15 indexed citations
19.
Guffanti, Monica, Andrea Caumo, Laura Galli, et al.. (2007). Switching to unboosted atazanavir improves glucose tolerance in highly pretreated HIV-1 infected subjects. European Journal of Endocrinology. 156(4). 503–509. 22 indexed citations
20.
Gianotti, Nicola, Monica Guffanti, Laura Galli, et al.. (2007). Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir. AIDS. 21(12). 1648–1651. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Guffanti Breakdown of academic impact, for papers by Salvatore Rocca Breakdown of academic impact, for papers by Fabienne Caby Breakdown of academic impact, for papers by P. de Truchis Breakdown of academic impact, for papers by L Caggese Breakdown of academic impact, for papers by Ana Barrios Breakdown of academic impact, for papers by Rosmeri Kuhmmer Lazzaretti Breakdown of academic impact, for papers by Shannon Schrader Breakdown of academic impact, for papers by Frederikke F. Rönsholt Breakdown of academic impact, for papers by Godfrey C. Burns
Rankless by CCL
2026